Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

230
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
230
Drug Therapy01:28

Drug Therapy

39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
39
Behavior Therapy01:22

Behavior Therapy

43
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
43
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

527
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
527
Anxiety: Overview01:18

Anxiety: Overview

248
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
248
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

367
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
367

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

I'm Concerned About Anxiety-What Do I Need to Know?

JAMA internal medicine·2026
Same author

Treatment of Anxiety for Adults in Primary Care Settings: A Review.

JAMA internal medicine·2026
Same author

Gender Identity and Mental Health Symptom Severity Among Adolescents Admitted to an Inpatient Psychiatric Hospital.

Child psychiatry and human development·2024
Same author

Addressing Residents' Fears of Violence: One Program's Residency Workshop to Address Fears of Violence and Teach Violence Risk Assessment.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2023
Same author

Mental Health Outcomes Among Transgender Veterans and Active-Duty Service Members in the United States: A Systematic Review.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2023
Same author

New-Onset Psychosis in the Context of COVID-19 Infection: An Illustrative Case and Literature Review.

Journal of the Academy of Consultation-Liaison Psychiatry·2023

Related Experiment Video

Updated: Jun 8, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.2K

Pharmacotherapy for Anxiety Disorders.

Kerry B O'Leary1, Jeffrey S Khan2

  • 1Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, 1 Baylor Plaza - BCM350, Houston, TX 77030, USA.

The Psychiatric Clinics of North America
|November 6, 2024
PubMed
Summary

Anxiety disorders, including GAD, PD, and SAD, are effectively treated with psychotherapy and pharmacotherapy, showing 60-85% efficacy. While current advancements are limited, research into novel pathways offers future treatment possibilities.

Keywords:
AnxietyGeneralized anxiety disorderPharmacotherapySelective serotonin reuptake inhibitorsSerotonin-norepinephrine reuptake inhibitors

More Related Videos

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

31.2K
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

18.0K

Related Experiment Videos

Last Updated: Jun 8, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
04:20

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

4.2K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

31.2K
Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice
14:40

Optogenetic Manipulation of Neuronal Activity to Modulate Behavior in Freely Moving Mice

Published on: October 27, 2020

18.0K

Area of Science:

  • Psychiatry
  • Pharmacology
  • Psychology

Background:

  • Anxiety disorders represent the most prevalent category of psychiatric conditions.
  • Common examples include generalized anxiety disorder (GAD), panic disorder (PD), and social anxiety disorder (SAD).

Purpose of the Study:

  • To summarize the current landscape of anxiety disorder treatments.
  • To highlight the efficacy of established therapeutic approaches.
  • To briefly touch upon future research directions.

Main Methods:

  • Literature review of existing studies on anxiety disorder treatments.
  • Analysis of efficacy rates for psychotherapy and pharmacotherapy.
  • Examination of first-line pharmacologic treatments for GAD, PD, and SAD.

Main Results:

  • Psychotherapy and pharmacotherapy demonstrate significant efficacy, ranging from 60% to 85%.
  • Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are primary pharmacologic interventions.
  • Treatment recommendations for pediatric and geriatric populations show minor variations but maintain consistent first-line options.

Conclusions:

  • Established treatments for anxiety disorders are highly effective.
  • Current advancements in treatment are minimal, but ongoing research into novel pathways holds promise for future therapeutic options.